CTRI/2018/01/011403
Completed
Phase 4
Evaluation of â??Quality of Lifeâ?? and in-use tolerance in women with facial melasma, after using a triple combination drug (TRI-LUMA Cream)
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Galderma India Private Limited
- Enrollment
- 33
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants with moderate to severe melasma on the face.
- •Childbearing potential patient with highly effective contraceptive methods
- •Willing to avoid unusual sun exposure as far as possible for the entire study duration.
Exclusion Criteria
- •Patients with prior history of mometasone based triple combination melasma therapy or under hormonal replacement therapy including usage of OC pills
- •If Patients were immunocompromised or were under immunosuppressive treatment, or had contraindications for corticosteroid treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
ASSESSMENT OF QUALITY OF LIFE OF TUBERCULOSIS PATIENTSCTRI/2021/11/038300I
Completed
N/A
Quality of Life in lung cancer patient with brain metastasis.CTRI/2013/01/003299A140
Recruiting
N/A
Application observation on quality of life and cohabitation problems in patients with the suburethral PVDF band DynaMesh®-SIS (soft)N39.3Stress incontinenceDRKS00033888FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH100
Completed
Phase 2
Comparison of Quality of life and Periodontal health status in pre and postmenopausal women. This is A Cross sectional studyCTRI/2020/03/024349none25
Not Yet Recruiting
N/A
Comparing Quality of Life: Psoriasis Patients vs. General Population - Insights from a Cross-Sectional StudyHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2024/05/067585Datta Meghe Institude of Higher Education and Research